-
1.
公开(公告)号:US08129423B2
公开(公告)日:2012-03-06
申请号:US11871318
申请日:2007-10-12
申请人: Jean Ackermann , Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander V. Mayweg , Werner Neidhart , Tadakatsu Takahashi
发明人: Jean Ackermann , Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander V. Mayweg , Werner Neidhart , Tadakatsu Takahashi
IPC分类号: A61K31/4152 , A61K31/4166 , C07D233/02
CPC分类号: C07D233/02 , A61K9/2054 , A61K9/4866 , C07D233/06 , C07D233/10 , C07D233/28 , C07D471/06 , C07D471/10
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 式的化合物及其药学上可接受的盐和酯,其中R 1至R 6具有权利要求1中给出的含义,可以以药物组合物的形式使用。
-
公开(公告)号:US07652057B2
公开(公告)日:2010-01-26
申请号:US11511542
申请日:2006-08-29
IPC分类号: A61K31/4152 , C07D231/08
CPC分类号: C07D231/20 , C07D231/22 , C07D231/26 , C07D231/54 , C07D231/56 , C07D471/04 , C07D487/04
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 式的化合物及其药学上可接受的盐和酯,其中R 1至R 4具有权利要求1中给出的含义,可以以药物组合物的形式使用。
-
公开(公告)号:US07547697B2
公开(公告)日:2009-06-16
申请号:US11824971
申请日:2007-07-02
IPC分类号: A61K31/502 , A61K31/504 , A61K31/5025 , A61K31/50 , C07D237/08 , C07D237/14 , C07D237/16 , C07D237/28 , C07D491/08 , A61P3/10 , A61P3/04 , A61P3/06 , A61P9/12 , C07D307/12 , C07C49/105 , C07C49/11 , C07C49/115 , C07C49/12 , C07C49/15
CPC分类号: C07D237/08
摘要: Compounds of formula (I): as well as pharmaceutically acceptable salts and esters thereof for use as pharmaceutical compositions.
摘要翻译: 式(I)化合物:及其药学上可接受的盐和酯,用作药物组合物。
-
公开(公告)号:US07678795B2
公开(公告)日:2010-03-16
申请号:US11481330
申请日:2006-07-05
IPC分类号: C07D237/36 , C07D237/28 , A61K31/502
CPC分类号: C07D403/04 , C07D237/08 , C07D237/26 , C07D237/28 , C07D417/04
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 式的化合物及其药学上可接受的盐和酯,其中R 1至R 4具有权利要求1中给出的含义,可以以药物组合物的形式使用。
-
公开(公告)号:US20080009499A1
公开(公告)日:2008-01-10
申请号:US11824971
申请日:2007-07-02
IPC分类号: A61K31/502 , A61P5/00 , C07D237/26
CPC分类号: C07D237/08
摘要: Compounds of formula (I): as well as pharmaceutically acceptable salts and esters thereof for use as pharmaceutical compositions.
摘要翻译: 式(I)化合物:及其药学上可接受的盐和酯,用作药物组合物。
-
公开(公告)号:US20070010519A1
公开(公告)日:2007-01-11
申请号:US11481330
申请日:2006-07-05
申请人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
发明人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
IPC分类号: A61K31/502 , C07D237/36 , C07D237/28
CPC分类号: C07D403/04 , C07D237/08 , C07D237/26 , C07D237/28 , C07D417/04
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 其中R 1至R 4具有权利要求1给出的含义的式及其药学上可接受的盐和酯的化合物可以以药物组合物的形式使用。
-
公开(公告)号:US20060074237A1
公开(公告)日:2006-04-06
申请号:US11238598
申请日:2005-09-29
申请人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
发明人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
IPC分类号: C07D417/02 , C07D413/02 , C07D401/02
CPC分类号: C07D213/76 , C07D401/12 , C07D413/04
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 其中R 1至R 6具有权利要求1中给出的含义的式及其药学上可接受的盐和酯的化合物可以以药物组合物的形式使用。
-
公开(公告)号:US07482341B2
公开(公告)日:2009-01-27
申请号:US11238598
申请日:2005-09-29
申请人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
发明人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
IPC分类号: C07D401/02 , A61K31/44
CPC分类号: C07D213/76 , C07D401/12 , C07D413/04
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 式的化合物及其药学上可接受的盐和酯,其中R 1至R 6具有权利要求1中给出的含义,可以以药物组合物的形式使用。
-
公开(公告)号:US20070049574A1
公开(公告)日:2007-03-01
申请号:US11511542
申请日:2006-08-29
申请人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
发明人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
IPC分类号: A61K31/55 , A61K31/4745 , A61K31/4439 , A61K31/426 , A61K31/416 , A61K31/4152 , C07D487/02 , C07D471/02 , C07D403/02
CPC分类号: C07D231/20 , C07D231/22 , C07D231/26 , C07D231/54 , C07D231/56 , C07D471/04 , C07D487/04
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 其中R 1至R 4具有权利要求1给出的含义的式及其药学上可接受的盐和酯的化合物可以以药物组合物的形式使用。
-
10.
公开(公告)号:US08211913B2
公开(公告)日:2012-07-03
申请号:US12372244
申请日:2009-02-17
申请人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
发明人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
IPC分类号: C07D213/02 , A61K31/44
CPC分类号: C07D213/76
摘要: Compounds of formula (I): as well as pharmaceutically acceptable salts and esters thereof used in the form of pharmaceutical compositions.
摘要翻译: 式(I)化合物及其药学上可接受的盐和酯以药物组合物的形式使用。
-
-
-
-
-
-
-
-
-